Why the study?
The study was conducted to determine whether novel oral anticoagulants are associated with a higher risk of inpatient epistaxis admission.
Does the use of oral anticoagulants increase the risk of inpatient epistaxis admission in adult patients?
Does the use of oral anticoagulants increase the risk of inpatient epistaxis admission in adult patients?
Vitamin K inhibitors, but not DOACs or platelet inhibitors, are associated with a significantly increased risk of inpatient admission for epistaxis.
No takes yet. Share an insight, caveat, or question.
DOACs not associated with higher epistaxis admission risk vs VKA; leaves open whether switching reduces admissions in practice.
Mitchell et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: